* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download epidemiology of respiratory tract infections
Survey
Document related concepts
Herpes simplex wikipedia , lookup
2015–16 Zika virus epidemic wikipedia , lookup
Ebola virus disease wikipedia , lookup
Hepatitis C wikipedia , lookup
Human cytomegalovirus wikipedia , lookup
Neonatal infection wikipedia , lookup
Hospital-acquired infection wikipedia , lookup
Orthohantavirus wikipedia , lookup
Marburg virus disease wikipedia , lookup
West Nile fever wikipedia , lookup
Swine influenza wikipedia , lookup
Herpes simplex virus wikipedia , lookup
Middle East respiratory syndrome wikipedia , lookup
Hepatitis B wikipedia , lookup
Transcript
EPIDEMIOLOGY OF RESPIRATORY TRACT INFECTIONS Respiratory tract is usually divided into three segments • • • The Upper Respiratory tract: This includes the nose, paranasal sinuses, and throat. The Respiratory Airways: This includes the trachea, bronchi, and bronchioles. The Lungs: This includes the respiratory bronchioles, alveolar ducts, alveolar sacs, and the alveoli. The following defense mechanisms in the alveoli protect the parenchymal cells from invasion by microorganisms – Alveolar macrophages (the most important) – Complement components – Alveolar lining fluid containing surfactant, phospholipids, neutral lipids, IgG, IgE, IgA, secretory IgA, certain complement components, Factor B, and other unidentified agents that maybe important in activation of alveolar macrophages – B cells, T cells, and null cells that can elicit a localized immune response to infection – Lymphoid tissue associated with the lungs Mechanisms used to avoid phagocytosis – Capsule production. (S. pneumoniae, H. influenza, B. anthracis, N. meningitidis, K. pneumoniae) – Toxin production. These toxins could include cytotoxins, leukocidins, and exotoxins. (examples; S. aureus produces leukocidins and cytotoxins. P. aeruginosa produces exotoxin A which destroys cells much like the diphtheria toxin does.) – Being too large to phagocytize. Parasites and fungi are often too large for the phagocyte to engulf. – Replication inside cells. Viruses and Chlamydia sp. are obligate intracellular parasites that replicate inside the cells of the lung avoiding the phagocyte. – Mimicry. Some parasites produce surface proteins which are very similar to host proteins or acquire host proteins and appear to the phagocyte as self. Some bacteria produce proteins that cause host proteins to bind to their surfaces (ex. protein A/Staphylcoccus aureus) Mechanisms used to survive in the phagocyte Inhibition of lysosome fusion with the phagosome. (Toxoplasma gondii, Aspergillus sp., Chlamydia psittaci) Escape from the phagosome. (Mycobacterium leprae, Trypanosoma cruzi, Influenza virus escapes the phagolysosome) Resistance to killing and digestion in the phagolysosome. (Mycobacterium tuberculosis, Nocardia sp., Yersinia pestis) Growth in the phagocytic cell. (M. tuberculosis, Legionella pneumophila, Cytomegalovirus) Entry into the phagocyte other than by phagocytosis. Some organisms avoid destruction by getting into the phagocyte's cytoplasm. No phagosome-lysosome fusion occurs and the organisms can survive in the phagocyte. (Toxoplasma gondii, some enveloped viruses) Nonbacterial Agents that Cause Upper Respiratory Tract Infections of Man Agents Human Serotypes Nucleic Date of Acid Types Discovery Myxoviruses Influenza A, B, C RNA Parainfluenza Respiratory Syncytial Virus Coronaviruses 1, 2, 3, 4 RNA 19331949 1953 1 (maybe 2) RNA 1956 1 RNA 1965 RNA 1960s RNA 1948 RNA 1948 RNA 1950s DNA 1953 DNA RNA + 1944 Picornaviruses Rhinoviruses- most > 100 types common cause. 24 (perhaps only A21 causes respiratory Coxsackie virus A illnesses) 6 (perhaps only B4, B5 cause respiratory Coxsackie virus B illnesses) 31 (perhaps only types 11, 20, 25 cause Echoviruses respiratory illnesses) 34 (types 1, 2, 3, 5, 7, 14, 21 are Adenoviruses responsible for respiratory illnesses) Mycoplasma 1 pneumoniae Flu and other respiratory tract infections Main nosologic forms Influenza; Parainfluenza; RSV infections; rhinovirus infections; adenovirus infections. (Flu, influenza) Acute viral illness with the direct mechanism of transmission of agent, distribution epidemic and pandemic; it is characterized by the infection of respiratory tracts, expressed intoxication, fever and moderate catarrhal phenomena. Key facts Influenza is an acute viral infection that spreads easily from person to person. Influenza circulates worldwide and can affect anybody in any age group. Influenza causes annual epidemics that peak during winter in temperate regions. Influenza is a serious public health problem that causes severe illnesses and deaths for higher risk populations. An epidemic can take an economic toll through lost workforce productivity, and strain health services. Vaccination is the most effective way to prevent infection. Flu agents–RNA-containing virions, size varying from 80 to 120 nm Different viral antigens of influenza A: 1918 A.D– H1N1; 1957A.D– H2N2; 1968A.D– H3N2; 1977A.D– H3N2 and H1N1. INFLUENZA VIRUS FORMULA: А/Singapore/1/57/H2N2 А/Honkong/1/68/H3N2 А/Victoria/35/72/H3N2 A/Texas/36/91/H1N1 SOURCES OF INFECTION: Healthy person in the latent period; Patient during whole period Disease lasting -7 days Recovery– it is proved that in individuals a virus can be conserved up to 14-15 days Birds. Infectious agent: H5N1, H7N7, H9N2 Epidemiology: • zoonotic • source of infection – poultry • mechanism of transmission – droplet?, fecal-oral? contact? • receptivity: mostly children Clinic: Flu-like symptoms: fever, sensitivity to cold, headache, pain in muscles and throat symptoms of eyes infection pneumonia History: in 1997 in to Hong Kong, virus H5N1 (18 people became ill, 6 died); in 1999 in to Hong Kong, virus H9N2 (became ill 2 children); in 2003 in to Hong Kong, virus H5N1 and H9N2 (became ill 3 persons, a 1 man died); in 2003 in Netherlands the virus H7N7 (89 people became ill, a 1 person died); in 2004 – flash of bird flu H5N1 among people in China, Thailand, Vietnam (35 persons died). Features of virus of bird flu 2004: The virus became more virulent, that testifies to his mutation The virus overcame an inter-specific barrier from birds to the man, however while there are no proofs of that an exciter is passed straight from a man to the man (all sick people had the direct contact with the infected birds) The virus will strike children mainly the source of exciter and ways of distribution of virus are not certain, that does a situation with distribution of virus not by practically controlled one measures on prevention to distribution – complete elimination all total number of birds of livestock Classification of flu (J10) Serologic types of virus: A (H1N1), (H2N2), (H3N2), B, C. Clinical forms: typical, atypical (afebrile, acatarrhal, hyper-acute). Degree of severity: mild, moderate, severe, very severe. Complication: pneumonia, otitis, sinusitis, tonsillitis, encephalitis, meningoencephalitis, pyelonephritis, pyelocystitis, cholangitis and others. Clinical differences of flu and other ARI Disease Beginning Body Temperature Intoxicatio n Damage of respiratory pathways Other damages Often Rare Trachitis Bronchitis - Rhinopharyngitis, trachitis - Kerato-conjuctivitis, lymphoadenopathy, hepato-splenomegaly. Influenza (flu) Acute Febrile (3-5 days) Developed Para-influenza Progressive, rarely acute Sub-febrile (till 2 weeks) Immeasura ble Laryngitis Progressive, acute Febrile (may present > 5 days, minimum 5 days) Mild Pharyngitis, rhinitis Pneumonia Mild Bronchiolitis Rhinopharyngitis, laryngitis, bronchitis, pneumonia Absent Rhinitis, serous secretions - Adenoviral infection Respiratory synctal viral infection Rhinoviral infection Acute and progressive Sub-febrile, rarely high (1-2 weeks) Acute Normal or subfebrile (1-3 days) - Differential diagnosis: tonsillitis; ornitosis; measles; enterovirous illness; typhoid; viral hepatitis; pneumonia; inflammation of additional cavities of nose. Treatment amantadine rimantadine Zanamivir (Relenza) oseltamivir (Tamiflu) ribavirin WHO recommends annual vaccination for (in order of priority) nursing-home residents (the elderly or disabled) elderly individuals people with chronic medical conditions other groups such as pregnant women, health care workers, those with essential functions in society, as well as children from ages six months to two years. Influenza vaccines are available in two forms: an intramuscular preparation containing formalin-inactivated virus and purified surface antigen an intranasal spray containing live attenuated viruses Vaccines : The “Vaxigrip” firms of Paster Mark “Fluorix” firms SmithClyayn Bichem “Influvac” firms Solvey Farma Influenza vaccine “Influvac”: components A/Sydney/455/97/H3N3, A/Beijing/263/95/H1N1 and B/Beijing/184/93. It is intended for adults children. Enter intramuscular or deeply hypodermic. A protective effect is achieved in 10 days after introduction. Proceeds during 1 year. This preliminary negative stained transmission electron micrograph depicts some of the ultrastructural morphology of the A/CA/4/09 swine flu virus. Courtesy of CDC/ C. S. Goldsmith and A. Balish. Phase 6 criteria: In addition to the criteria defined in Phase 5, the same virus has caused sustained community-level outbreaks in at least one other country in another WHO region. Courtesy of the WHO. Adenovirus Conjunctivitis during adenoviral infections: Pharyngo-conjunctivit is fever Treatment: Bed regimen milk-vegetable vitamin diet inhalations with addition in the aerosol of lemon acid 1:1000 or juice of lemon, boric acid 1:100 reflex-therapy and laser-therapy antiviral preparations: remantadin, leucocytic interferon, amixin, cycloferon, amizon Indication for antibiotic therapy Very severe flu (hyper toxic form with the phenomena of encephalitis, beginning from pneumonia) flu in children the first 2 years of life, pregnant, very weakened, persons senile and old age bacterial complications accompanying chronic diseases Prophylaxis of flu and other ARI: Seasonal measures Increasing the resistance of persons, reflexotherapy, UV-rays Inductors of interferon secretion adaptogens (extract eleoterococa, tincture arali, gin-sing) Urgent measures Antiviral drugs Immunostimulators ointment of oxoline Leukocytic interferon Anti-influenza immunoglobulin